PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 31.41M |
| December 31, 2022 | 23.94M |
| June 30, 2022 | 45.49M |
| December 31, 2021 | 49.73M |
| June 30, 2021 | 56.46M |
| December 31, 2020 | 66.25M |
| June 30, 2020 | 42.74M |
| December 31, 2019 | 36.95M |
| September 30, 2019 | 35.62M |
| June 30, 2019 | 32.44M |
| December 31, 2018 | 25.44M |
| June 30, 2018 | 21.21M |
| December 31, 2017 | 16.60M |
| June 30, 2017 | 13.31M |
| Date | Value |
|---|---|
| June 30, 2017 | 13.31M |
| December 31, 2016 | 9.862M |
| June 30, 2016 | 7.538M |
| June 30, 2016 | 7.538M |
| December 31, 2015 | 6.420M |
| June 30, 2015 | 6.040M |
| June 30, 2015 | 6.040M |
| December 31, 2014 | 5.816M |
| June 30, 2014 | 5.086M |
| June 30, 2014 | 5.086M |
| December 31, 2013 | 6.024M |
| June 30, 2013 | 6.138M |
| June 30, 2013 | 6.138M |
| December 31, 2012 | 18.74M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
23.94M
Minimum
Dec 2022
66.25M
Maximum
Dec 2020
42.10M
Average
39.84M
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 34.24M |
| Cellectis SA | 249.58M |
| Genfit SA | 117.09M |
| Innate Pharma SA | 146.24M |
| Inventiva SA | 112.30M |